Overview

Treatment of Orthostatic Hypotension in SCI

Status:
Not yet recruiting
Trial end date:
2026-06-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to identify the effects of non-pharmacological and pharmacological anti-hypotensive treatment interventions on orthostatic hemodynamic responses, symptoms of autonomic dysreflexia and orthostatic hypotension, and levels of fatigue and comfort in hypotensive individuals with SCI.
Phase:
Phase 4
Details
Lead Sponsor:
James J. Peters Veterans Affairs Medical Center
Collaborator:
Kessler Foundation
Treatments:
Droxidopa
Midodrine